BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,529 | +1047.5% | 130 | +1344.4% | 0.00% | – |
| Q2 2023 | $569 | +40.5% | 9 | 0.0% | 0.00% | – |
| Q1 2023 | $405 | – | 9 | +50.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 6 | -71.4% | 0.00% | – |
| Q1 2022 | $1,000 | -93.8% | 21 | -85.8% | 0.00% | -100.0% |
| Q4 2021 | $16,000 | +6.7% | 148 | -1.3% | 0.00% | 0.0% |
| Q3 2021 | $15,000 | +650.0% | 150 | +614.3% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 21 | -34.4% | 0.00% | – |
| Q1 2021 | $3,000 | +50.0% | 32 | +52.4% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 21 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | +100.0% | 21 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 21 | -38.2% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 34 | +54.5% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 22 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 22 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | +100.0% | 22 | +37.5% | 0.00% | – |
| Q2 2018 | $1,000 | – | 16 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |